Sodium Dichloroacetate丨CAS 2156-56-1

Sodium dichloroacetate丨2156-56-1 is a chlorinated organic compound that is widely studied for its potential therapeutic and biochemical properties. It is the sodium salt of dichloroacetic acid (DCA) and has attracted attention for its ability to modulate cellular metabolism, particularly by influencing lactate metabolism and mitochondrial function.

Cancer Therapy:

Targeting Tumor Metabolism: Sodium dichloroacetate丨2156-56-1 has gained interest in cancer research due to its ability to shift cancer cell metabolism from anaerobic glycolysis (the Warburg effect) to aerobic respiration. Many cancer cells rely heavily on glycolysis for energy production, even in the presence of oxygen (known as the Warburg effect). By promoting mitochondrial oxidative phosphorylation, sodium dichloroacetate could reduce tumor growth and metastasis.

Clinical Studies: Several clinical trials and preclinical studies have suggested that sodium dichloroacetate may be effective in slowing the growth of solid tumors and leukemia by inducing cellular apoptosis and reducing the survival of cancer cells. However, more research is needed to fully understand its role and effectiveness in cancer treatment.

Lactic Acidosis:

Treatment of Lactic Acidosis: Sodium dichloroacetate is used as an experimental treatment for lactic acidosis, a condition characterized by the accumulation of lactic acid in the bloodstream. This condition can result from metabolic disorders, hypoxia, or certain drugs. By enhancing pyruvate metabolism and reducing lactate production, sodium dichloroacetate can help correct this metabolic imbalance.

Mitochondrial Diseases:

Neurodegenerative Diseases: Some research has investigated the potential of sodium dichloroacetate in the treatment of mitochondrial diseases, where there is dysfunction in oxidative phosphorylation. Diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) may benefit from the effects of sodium dichloroacetate in enhancing mitochondrial ATP production and promoting aerobic metabolism.

Cellular Energy Deficiencies: In conditions where there is a deficiency of ATP due to mitochondrial dysfunction, sodium dichloroacetate may help increase energy production in neurons and other tissues.

Diabetes:

Some research suggests that sodium dichloroacetate may have potential in type 2 diabetes by improving insulin sensitivity and glycolytic metabolism. It may help balance glucose metabolism, making it a potential candidate for diabetes management, although its use for this purpose requires further investigation.

Acid-Base Balance:

Sodium dichloroacetate丨2156-56-1 may be used experimentally to help balance acid-base disorders by reducing acid buildup in the body, which can be beneficial in conditions like chronic kidney disease and renal acidosis.

1.Targeted Metabolic Effect:

Sodium dichloroacetate丨2156-56-1 specifically targets pyruvate metabolism and mitochondrial function, making it a precise therapeutic agent for diseases associated with metabolic dysregulation.

2.Reduction of Lactic Acid:

By decreasing lactate production, Sodium dichloroacetate丨2156-56-1 can help reduce lactic acidosis, a potentially dangerous condition seen in metabolic disorders, cancers, and critical care settings.

3.Cancer Treatment Potential:

Its ability to disrupt the Warburg effect and shift energy production toward oxidative phosphorylation makes it an interesting candidate in the fight against cancer, where metabolic rewiring is a hallmark of malignancy.

4.Mitochondrial Support:

It has the potential to enhance mitochondrial function, which could be beneficial in treating neurodegenerative diseases, mitochondrial myopathies, and other disorders where mitochondrial energy production is compromised.

5.Low Toxicity:

Sodium dichloroacetate is generally considered to have low toxicity compared to other chemotherapeutic agents, making it a relatively safe option for further investigation in clinical settings.

Sodium dichloroacetate丨2156-56-1 is a metabolic modulator with significant potential in the treatment of metabolic disorders, cancer, lactic acidosis, and mitochondrial diseases. By altering pyruvate metabolism and enhancing mitochondrial function, it offers a unique approach to treating conditions where metabolic dysregulation plays a critical role. While the compound shows promise in several therapeutic areas, its use must be carefully monitored due to potential liver toxicity and neurological side effects. Ongoing research is needed to establish its safety and efficacy in clinical practice.